Reaction of achiral 2,5-diphenyl-3,4-di(3-pyridyl)cyclopenta-2,4-dien-1-one (2) with ZnCl2 and HgBr2, respectively, afforded the helically chiral coordination polymers [(2)ZnCl2]infinity and [(2)HgBr2]infinity, which show spontaneous chiral resolution, forming colonies of homochiral crystals.
The aromatic compounds fluorenone (1) and 4,5-diazafluoren-9-one (2) behave like cyclopentadienones in their reaction with [Cp*Co(C 2 H 4 ) 2 ] (3a), affording the sandwich-type complexes [Cp*Co(η 4 -1)] ( 4) and [Cp*Co(η 4 -2)] ( 5), respectively, whose structures have been determined by X-ray diffraction. Both complexes show double-bond fixation in their η 2 -coordinated sixmembered rings and belong to a new structure type of mononuclear organometallics. The cobalt-coordinated ligands 1 and 2 present in 4 and 5, respectively, may be replaced by two molecules of carbon monoxide. In accord with their cyclopentadienone-like nature, they are nucleophilic and undergo O-acylation with acetyl chloride, affording cobaltocenium species.
2,5-Diphenyl-3,4-bis(2-pyridyl)cyclopenta-2,4-dien-1-one (1), a close relative of tetraphenylcyclopentadienone, is a new ligand platform for use in redox switches and sensors. Compound 1 acts as a molecular electrochemical sensor towards a range of divalent metal ions and exhibits favourable two-wave behaviour. It forms chelates of the type [(1)MX2], whose stability is enhanced by five orders of magnitude upon one-electron reduction. The bite angle of 1 is close to 90 degrees in these complexes. The attachment of the 14-valence-electron Cp*Co fragment to the cyclopentadienone pi system reduces the bite angle and thus modulates the binding characteristics of 1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.